Cargando…

HIV vaccine trial safety and retention among 18-20 year olds in the HVTN 503/Phambili study support the inclusion of adolescents in future trials

Detalles Bibliográficos
Autores principales:	Volk, JE, Hessol, NA, Gray, GE, Kublin, JG, Churchyard, G, Mlisana, K, Nchabeleng, M, Buchbinder, SP, Bekker, L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441785/ http://dx.doi.org/10.1186/1742-4690-9-S2-P131

Ejemplares similares

Pregnancy Incidence and Correlates during the HVTN 503 Phambili HIV Vaccine Trial Conducted among South African Women
por: Latka, Mary H., et al.
Publicado: (2012)

P15-08. Did unblinding affect HIV risk behaviour and risk perception in the HVTN503/Phambili study?
por: Gray, GE, et al.
Publicado: (2009)

P13-05. Factors associated with pregnancy during the HVTN 503/Phambili trial, a phase IIB HIV trial of the Merck Ad-5 multi-clade HIV vaccine
por: Latka, M, et al.
Publicado: (2009)

P15-13. HVTN 503(Phambili) trial discontinuation of enrolment/vaccination: the impact on trial participant attitudes to vaccine trials and scientific research
por: Mark, D, et al.
Publicado: (2009)

Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef Vaccine Induced Immune Responses
por: Hopkins, Kathryn L., et al.
Publicado: (2014)

P14-07. Offering new prevention modalities in HIV vaccine trials: experience with male circumcision in the Phambili trial
por: de Bruyn, G, et al.
Publicado: (2009)

P14-02. Social impact events in Phambili, the first phase 2B HIV vaccine trial in South Africa
por: Allen, MA, et al.
Publicado: (2009)

Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men
por: Moodie, Zoe, et al.
Publicado: (2015)

Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial
por: Mpofu, Rephaim, et al.
Publicado: (2021)

Uptake of Genital Mucosal Sampling in HVTN 097, a Phase 1b HIV Vaccine Trial in South Africa
por: Lazarus, Erica Maxine, et al.
Publicado: (2014)

Feasibility of recruiting high-risk women in the US for HIV vaccine efficacy trials (HVTN 906)
por: Koblin, B, et al.
Publicado: (2012)

A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204)
por: Churchyard, Gavin J., et al.
Publicado: (2011)

P15-15. Advocates' perspectives on community engagement in the HVTN 505
por: Warren, M, et al.
Publicado: (2009)

Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial
por: Fong, Youyi, et al.
Publicado: (2018)

Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial
por: Pantaleo, Giuseppe, et al.
Publicado: (2019)

2896. Oral PrEP Uptake among HVTN 704/HPTN 085 Participants: Implications for the Future of Biomedical HIV Prevention Trials
por: Cantos, Valeria D, et al.
Publicado: (2023)

Discovery medicine – the HVTN's iterative approach to developing an HIV-1 broadly neutralizing vaccine
por: Martin, Troy M., et al.
Publicado: (2023)

Safety and Immunogenicity of a Replication-Defective Adenovirus Type 5 HIV Vaccine in Ad5-Seronegative Persons: A Randomized Clinical Trial (HVTN 054)
por: Peiperl, Laurence, et al.
Publicado: (2010)

Correction to: Impact of Point-of-Care Testing on the Management of Sexually Transmitted Infections in South Africa: Evidence from the HVTN702 Human Immunodeficiency Virus Vaccine Trial
Publicado: (2022)

Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines
por: Laher, Fatima, et al.
Publicado: (2020)

Poster Sessions 313-503
Publicado: (2004)

LncRNA ZNF503-AS1 promotes RPE differentiation by downregulating ZNF503 expression
por: Chen, Xue, et al.
Publicado: (2017)

Clinical research nurse predictions of trial failure, recruitment and retention: a case for their early inclusion in trial design
por: Shiely, Frances, et al.
Publicado: (2023)

Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120
por: deCamp, Allan C., et al.
Publicado: (2017)

Treatment of 503 cattle with traumatic reticuloperitonitis
por: Braun, Ueli, et al.
Publicado: (2018)

Scientific opinion of Flavouring Group Evaluation 503 (FGE.503): grill flavour ‘Grillin’ CB‐200SF’
por: Silano, Vittorio, et al.
Publicado: (2017)

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)
por: Fuchs, Jonathan D., et al.
Publicado: (2015)

1558. Associations between gender identity and solicited adverse events after passive infusion of VRC01 or placebo in HVTN 704/HPTN 085
por: Theodore, Deborah, et al.
Publicado: (2023)

Clinical and laboratory findings in 503 cattle with traumatic reticuloperitonitis
por: Braun, Ueli, et al.
Publicado: (2018)

In memoriam: Gita Ramjee
por: Bekker, Linda‐Gail, et al.
Publicado: (2020)

Effect of Social Determinants of Health on Uncontrolled Human Immunodeficiency Virus (HIV) Infection Among Persons With HIV in San Francisco, California
por: Melo, Jason S, et al.
Publicado: (2022)

Inclusion and exclusion criteria used in non-specific low back pain trials: a review of randomised controlled trials published between 2006 and 2012
por: Amundsen, Pål André, et al.
Publicado: (2018)

Optics studies based on V6.503 nominal configuration
por: Aiba, M, et al.
Publicado: (2009)

503 Peculiarities of Immune Response in Young Children with Recurrent Wheezing
por: Gromadina, Olga, et al.
Publicado: (2012)

503. The Misappropriation of COVID-19 Related TV Ad Expenditures
por: Vyas, Kartavya J
Publicado: (2020)

Strategies to improve diversity, equity, and inclusion in clinical trials
por: Kahn, Justine M., et al.
Publicado: (2021)

PM503. Spatial components of magnetic mismatch negativity and the cortical thickness of its structural correlates in schizophrenia
por: Seol, Jiyoon Jasmine, et al.
Publicado: (2016)

Strategies to improve retention in randomised trials
por: Brueton, Valerie C, et al.
Publicado: (2013)

Inclusion of women in clinical trials
por: Berlin, Jesse A, et al.
Publicado: (2009)

Inclusion and diversity in the PRINCIPLE trial
por: Patel, Mahendra G, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l00gs29c50nd7fjd5csjtip4mj